pI: 6.6025 |
Length (AA): 472 |
MW (Da): 53313 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 469 | 5jjt (A) | 10 | 479 | 53.00 | 0 | 1 | 1.73039 | -1.32 |
74 | 111 | 2vsy (A) | 23 | 60 | 21.00 | 0 | 0.36 | 0.332208 | -0.3 |
161 | 466 | 3icf (A) | 190 | 507 | 43.00 | 0 | 1 | 1.28701 | -1.86 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128254)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G42810 | serine/threonine-protein phosphatase 5 |
Babesia bovis | BBOV_IV000160 | serine/threonine protein phosphatase 5 |
Brugia malayi | Bm1_15955 | serine/threonine protein phosphatase 5 |
Candida albicans | CaO19.1673 | potential calcineurin-like serine/threonine phosphatase similar to S. cerevisiae PPT1 (YGR123C) |
Candida albicans | CaO19.9242 | potential calcineurin-like Serine/Threonine phosphatase similar to S. cerevisiae PPT1 (YGR123C) |
Caenorhabditis elegans | CELE_Y39B6A.2 | Protein PPH-5, isoform B |
Cryptosporidium hominis | Chro.20310 | phosphoprotein phosphatase -related |
Cryptosporidium parvum | cgd2_2960 | phosphoprotein phosphatase related, putative |
Dictyostelium discoideum | DDB_G0283157 | hypothetical protein |
Drosophila melanogaster | Dmel_CG8402 | Protein phosphatase D3 |
Echinococcus granulosus | EgrG_001102500 | protein phosphatase 5 |
Entamoeba histolytica | EHI_162200 | protein phosphatase, putative |
Echinococcus multilocularis | EmuJ_001102500 | protein phosphatase 5 |
Homo sapiens | ENSG00000011485 | protein phosphatase 5, catalytic subunit |
Leishmania braziliensis | LbrM.18.0170 | serine/threonine protein phosphatase type 5, putative |
Leishmania donovani | LdBPK_180150.1 | serine/threonine protein phosphatase type 5, putative |
Leishmania infantum | LinJ.18.0150 | serine/threonine protein phosphatase type 5, putative |
Leishmania major | LmjF.18.0150 | serine/threonine protein phosphatase type 5, putative |
Leishmania mexicana | LmxM.18.0150 | serine/threonine protein phosphatase type 5, putative |
Loa Loa (eye worm) | LOAG_03443 | serine/threonine protein phosphatase 5 |
Loa Loa (eye worm) | LOAG_12431 | protein phosphatase 5 |
Mus musculus | ENSMUSG00000003099 | protein phosphatase 5, catalytic subunit |
Neospora caninum | NCLIV_055800 | Serine/threonine protein phosphatase 5 (EC 3.1.3.16), related |
Oryza sativa | 4338070 | Os05g0204900 |
Plasmodium berghei | PBANKA_1131900 | serine/threonine protein phosphatase 5 |
Plasmodium falciparum | PF3D7_1355500 | serine/threonine protein phosphatase 5 |
Plasmodium knowlesi | PKNH_1116000 | serine/threonine protein phosphatase 5, putative |
Plasmodium vivax | PVX_114750 | serine/threonine protein phosphatase 5, putative |
Plasmodium yoelii | PY04697 | serine/threonine protein phosphatase PP5 |
Saccharomyces cerevisiae | YGR123C | Ppt1p |
Schistosoma japonicum | Sjp_0010280 | ko:K04460 protein phosphatase 5, putative |
Schistosoma mansoni | Smp_090860 | protein phosphatase-5 |
Schmidtea mediterranea | mk4.013727.00 | |
Schmidtea mediterranea | mk4.055730.00 | |
Trypanosoma brucei gambiense | Tbg972.10.16800 | serine/threonine protein phosphatase type 5, putative |
Trypanosoma brucei | Tb927.10.13670 | serine/threonine protein phosphatase 5 |
Trypanosoma congolense | TcIL3000_10_13810 | serine/threonine protein phosphatase 5 |
Trypanosoma cruzi | TcCLB.507993.190 | serine/threonine protein phosphatase type 5, putative |
Trypanosoma cruzi | TcCLB.511277.630 | serine/threonine protein phosphatase type 5, putative |
Toxoplasma gondii | TGME49_312200 | serine/threonine protein phosphatase |
Theileria parva | TP02_0944 | serine/threonine protein phosphatase, putative |
Trichomonas vaginalis | TVAG_077920 | protein phosphatase-5, putative |
Trichomonas vaginalis | TVAG_331100 | protein phosphatase-1, putative |
Trichomonas vaginalis | TVAG_203890 | protein phosphatase-1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.13670 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.13670 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.13670 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.13670 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y39B6A.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_1131900 | Plasmodium berghei | Dispensable | plasmo |
TGME49_312200 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | protein phosphatase 5, catalytic subunit | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
Tb927.10.13670 | cloned gene | BRENDA | A gene with this EC number or name or sequence has been cloned from Trypanosoma brucei ( 1 ) |
23 literature references were collected for this gene.